JROOF News Alert Jericho Oil Corp (JROOF) 0.3957 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Jericho Oil Corp (JROOF) 0.3957 $JROOF

Jericho Oil Announces DTC Eligibility of its Common Shares
PR Newswire - Tue Feb 10, 7:30AM CST
Company to Attend 2015 NAPE Summit in Houston
JCO.VN: 0.490 (+0.055)

Jericho Expands into Oklahoma Adding Acreage and Production
PR Newswire - Fri Jan 23, 7:30AM CST
Company continues its growth, adds 2,050 acres in newest acquisition
JCO.VN: 0.490 (+0.055)

Jericho Oil Exits 2014 with Record Monthly Production
CNW Group - Fri Jan 16, 7:30AM CST
Gross Production Exceeds 3,850 Barrels during December
JCO.VN: 0.490 (+0.055)

Jericho Oil Updates Shareholders on 4th Quarter Activities with Production Exceeding 100 BOPD - Video News Alert on InvestmentPitch.com
Newsfile Corp - Fri Dec 12, 11:47AM CST
full story)
JCO.VN: 0.490 (+0.055)

Jericho Oil Provides Q4 Operational Update
PR Newswire - Tue Dec 09, 3:01PM CST
Jericho Continues to Successfully Execute Shallow Drill Program on Contiguous and Proximate Acreage- Gross Production Averages over 100 BOPD during Quarter
JCO.VN: 0.490 (+0.055)

Merriman Capital Announces Sponsorship of Jericho Oil Corp. on OTCQX
Thomson Reuters ONE - Mon Dec 01, 8:01AM CST
SAN FRANCISCO - December 1, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced today that it will serve as the Principal American Liaison (PAL) for Jericho Oil Corp. (OTCQX: JROOF) ("Jericho Oil" as it begins trading on the OTC market's highest tier, the OTCQX(R).

Jericho Oil Commences Trading in the U.S. on the OTCQX®
PR Newswire - Mon Dec 01, 7:00AM CST
Jericho Oil Corporation ("Jericho" or the "Company" (TSX-V: JCO, OTCQX: JROOF), a growth-oriented oil company engaged in the acquisition, exploration, development and production of overlooked and undervalued oil properties in North America, announces that its common shares will commence trading on the OTCQX® marketplace in the U.S., effective Dec. 1, 2014 under the symbol JROOF.
JCO.VN: 0.490 (+0.055)

OTC Markets Group Welcomes Jericho Oil to OTCQX®
PR Newswire - Mon Dec 01, 6:00AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced Jericho Oil Corp (TSX-V: JCO; OTCQX: JROOF), a growth-oriented oil company engaged in the acquisition, exploration, development and production of overlooked and undervalued oil properties in North America, has qualified to trade on OTCQX®, the best marketplace.
JCO.VN: 0.490 (+0.055)

Jericho Oil to Present at the 7th Annual LD Micro Conference on December 4th, 2014 in Los Angeles
PR Newswire - Tue Nov 18, 7:30AM CST
Jericho Oil Corporation ("Jericho" or the "Company" (TSX-V: JCO, OTC Markets: JROOF), a growth-oriented oil company engaged in the acquisition, exploration, development and production of overlooked and undervalued oil properties in North America, announces that it will be presenting at the LD Micro VII ("Main Event" Conference, which will be held December 2-4, 2014 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.
JCO.VN: 0.490 (+0.055)

Ryan D. Breen Non GST Trust: Shareholder Early Warning News Release
Marketwired - Mon Oct 20, 11:44AM CDT
The Ryan D. Breen Non GST Trust ("Breen Trust" has acquired direct ownership of 2,200,000 common shares of Jericho Oil Corporation (TSX VENTURE: JCO) (the "Issuer" . The acquired common shares together with existing holdings of 3,666,667 common shares represent 12.89% of the current issued and outstanding common shares of the Issuer.
JCO.VN: 0.490 (+0.055)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading